Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
Scope of the Report:
Asia-Pacific Antivenom market is valued at 285.00 million USD in 2017 and is expected to reach 359.23 million USD by the end of 2023, growing at a CAGR of 43.93% between 2016 and 2022.
The price of Antivenom is slightly increased in nearly five years. For being accorded with the corresponding application area, the product price has a large differences.
Despite the presence of competition problems, due to the global recovery trend is clear, investors are still optimistic about this areas, the future will still have more new investment enter the field.
The worldwide market for Antivenom is expected to grow at a CAGR of roughly 2.5% over the next five years, will reach 960 million US$ in 2024, from 830 million US$ in 2019, according to a new WMR study.
This report focuses on the Antivenom in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Merck & Co.
Haffkine Bio-Pharmaceutical Corporation
Rare Disease Therapeutics
Bharat Serums and Vaccines
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antivenom product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antivenom, with price, sales, revenue and global market share of Antivenom in 2017 and 2018.
Chapter 3, the Antivenom competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antivenom breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Antivenom market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Antivenom sales channel, distributors, customers, research findings and conclusion, appendix and data source.